Matches in SemOpenAlex for { <https://semopenalex.org/work/W2068499457> ?p ?o ?g. }
- W2068499457 endingPage "999" @default.
- W2068499457 startingPage "993" @default.
- W2068499457 abstract "In chronic obstructive pulmonary disease (COPD) which consists of emphysema and chronic bronchitis, alveolar tissue and/or bronchiolar walls are progressively destroyed. This suggests cell death by necrosis and/or apoptosis although no direct evidence of apoptosis has been reported. It was speculated that the apoptosis-related factors are associated with the progression of COPD. Fas/Apo-1 receptor (Fas), Fas ligand (Fas-L) and soluble Fas ligand (sFas-L) are inducers, while soluble Fas (sFas) is an inhibitor of apoptosis. In this study, plasma sFas and sFas-L were measured in 19 COPD patients receiving supplemental O2 (severe COPD) and 20 COPD patients not receiving supplemental O2 (mild/moderate COPD). Twenty-two age- and sex-matched healthy volunteers (healthy controls) and 20 patients receiving supplemental O2 and with level of hypoxaemia similar to severe COPD due to other pulmonary diseases (disease controls) were also examined. Plasma sFas-L was within normal limits in all groups. Plasma sFas levels were similar among healthy controls, disease controls, and mild/moderate COPD patients, but significantly increased in severe COPD (2.6 +/- 1.1, 2.6 +/- 0.2, 2.8 +/- 0.2 and 4.8 +/- 1.0 ng ml-1, respectively). Although PaO2 was lower in severe COPD than in mild/moderate COPD, and PaCO2 was higher in severe COPD than in mild/moderate COPD, they were close between severe COPD and disease controls. Tumour necrosis factor-alpha (TNF-alpha), interleukin 6 (IL-6) and C-reactive protein (CRP) were increased in patients with COPD, but were similar in both severe and mild/moderate COPD patients. We conclude that increased plasma sFas, which is independent of hypoxaemia, and increases in PaCO2, TNF-alpha, IL-6 and inflammation, may be associated with progression of COPD." @default.
- W2068499457 created "2016-06-24" @default.
- W2068499457 creator A5000878423 @default.
- W2068499457 creator A5000978481 @default.
- W2068499457 creator A5002601801 @default.
- W2068499457 creator A5013634345 @default.
- W2068499457 creator A5019887231 @default.
- W2068499457 creator A5022669876 @default.
- W2068499457 creator A5029791590 @default.
- W2068499457 creator A5075593407 @default.
- W2068499457 creator A5077773904 @default.
- W2068499457 creator A5079627454 @default.
- W2068499457 creator A5082894446 @default.
- W2068499457 creator A5088150727 @default.
- W2068499457 date "1998-08-01" @default.
- W2068499457 modified "2023-10-16" @default.
- W2068499457 title "An increase of soluble Fas, an inhibitor of apoptosis, associated with progression of COPD" @default.
- W2068499457 cites W1517945724 @default.
- W2068499457 cites W1971497198 @default.
- W2068499457 cites W1973792489 @default.
- W2068499457 cites W1975336660 @default.
- W2068499457 cites W1976692354 @default.
- W2068499457 cites W1984696190 @default.
- W2068499457 cites W1991865867 @default.
- W2068499457 cites W2005137750 @default.
- W2068499457 cites W2021095654 @default.
- W2068499457 cites W2023809975 @default.
- W2068499457 cites W2027998544 @default.
- W2068499457 cites W2041466047 @default.
- W2068499457 cites W2048457755 @default.
- W2068499457 cites W2048754442 @default.
- W2068499457 cites W2065338281 @default.
- W2068499457 cites W2068315718 @default.
- W2068499457 cites W2075809552 @default.
- W2068499457 cites W2091140279 @default.
- W2068499457 cites W2101462909 @default.
- W2068499457 cites W2117594247 @default.
- W2068499457 cites W2126475210 @default.
- W2068499457 cites W2143996326 @default.
- W2068499457 cites W2164802863 @default.
- W2068499457 cites W2232248512 @default.
- W2068499457 cites W2257255313 @default.
- W2068499457 cites W2265871020 @default.
- W2068499457 doi "https://doi.org/10.1016/s0954-6111(98)90343-2" @default.
- W2068499457 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9893764" @default.
- W2068499457 hasPublicationYear "1998" @default.
- W2068499457 type Work @default.
- W2068499457 sameAs 2068499457 @default.
- W2068499457 citedByCount "91" @default.
- W2068499457 countsByYear W20684994572012 @default.
- W2068499457 countsByYear W20684994572013 @default.
- W2068499457 countsByYear W20684994572014 @default.
- W2068499457 countsByYear W20684994572015 @default.
- W2068499457 countsByYear W20684994572016 @default.
- W2068499457 countsByYear W20684994572017 @default.
- W2068499457 countsByYear W20684994572018 @default.
- W2068499457 countsByYear W20684994572019 @default.
- W2068499457 countsByYear W20684994572020 @default.
- W2068499457 countsByYear W20684994572021 @default.
- W2068499457 countsByYear W20684994572022 @default.
- W2068499457 countsByYear W20684994572023 @default.
- W2068499457 crossrefType "journal-article" @default.
- W2068499457 hasAuthorship W2068499457A5000878423 @default.
- W2068499457 hasAuthorship W2068499457A5000978481 @default.
- W2068499457 hasAuthorship W2068499457A5002601801 @default.
- W2068499457 hasAuthorship W2068499457A5013634345 @default.
- W2068499457 hasAuthorship W2068499457A5019887231 @default.
- W2068499457 hasAuthorship W2068499457A5022669876 @default.
- W2068499457 hasAuthorship W2068499457A5029791590 @default.
- W2068499457 hasAuthorship W2068499457A5075593407 @default.
- W2068499457 hasAuthorship W2068499457A5077773904 @default.
- W2068499457 hasAuthorship W2068499457A5079627454 @default.
- W2068499457 hasAuthorship W2068499457A5082894446 @default.
- W2068499457 hasAuthorship W2068499457A5088150727 @default.
- W2068499457 hasBestOaLocation W20684994571 @default.
- W2068499457 hasConcept C126322002 @default.
- W2068499457 hasConcept C134018914 @default.
- W2068499457 hasConcept C17991360 @default.
- W2068499457 hasConcept C190283241 @default.
- W2068499457 hasConcept C203014093 @default.
- W2068499457 hasConcept C2776780178 @default.
- W2068499457 hasConcept C2992694001 @default.
- W2068499457 hasConcept C31573885 @default.
- W2068499457 hasConcept C55493867 @default.
- W2068499457 hasConcept C66008609 @default.
- W2068499457 hasConcept C71924100 @default.
- W2068499457 hasConcept C86803240 @default.
- W2068499457 hasConcept C90924648 @default.
- W2068499457 hasConceptScore W2068499457C126322002 @default.
- W2068499457 hasConceptScore W2068499457C134018914 @default.
- W2068499457 hasConceptScore W2068499457C17991360 @default.
- W2068499457 hasConceptScore W2068499457C190283241 @default.
- W2068499457 hasConceptScore W2068499457C203014093 @default.
- W2068499457 hasConceptScore W2068499457C2776780178 @default.
- W2068499457 hasConceptScore W2068499457C2992694001 @default.
- W2068499457 hasConceptScore W2068499457C31573885 @default.
- W2068499457 hasConceptScore W2068499457C55493867 @default.
- W2068499457 hasConceptScore W2068499457C66008609 @default.